Rare Disease Funding: A Spotlight on Saudi Arabia
The Gulf Cooperation Council (GCC) region is experiencing significant economic growth including in the healthcare... Read More
Digital Health in the UAE: Trends Post-COVID-19
The UAE's digital health sector is experiencing rapid growth, driven by government support and increased... Read More
Beyond Borders: French & English HTA Influence in Saudi Arabia
Rising medicine costs and limited healthcare budgets highlight the need to optimize public resource allocation.... Read More
Medical Devices: Pathways to Market and Future Outlook in the Middle East & Africa
Many governments in the Middle East and Africa are actively working to improve healthcare access... Read More
Guide to Successful Distributor and Manufacturer Relationships in the GCC
To enter the GCC market, international pharmaceutical and biotech companies are required to either establish... Read More
The Evolving Biosimilar Policy Landscape in the Middle East
Biosimilar adoption level can vary depending on factors such as the specific healthcare systems, the... Read More
HTA Changes in MENA: What Does the Future Hold for New Product Launches in the Region?
There is growing interest in pharmacoeconomic principles across the Middle East and Africa region. The... Read More
Commercializing Innovations: Rethinking the Optimal Launch Strategy and Launch Sequencing
From the declining economic growth rate to the increase in inflation at a global level... Read More
ATMPs: Critical success drivers for the achievement of premium pricing in Saudi Arabia
The Saudi Arabian pharmaceutical market is regarded as one of the fastest growing in the... Read More
